Molecular characterization of resistance to macrolides in Bartonella henselae

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 3192-3193

  Biswas, Silpak ^a   Raoult, Didier ^a   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; MACROLIDE; RIBOSOME PROTEIN; RIBOSOME PROTEIN L22; RIBOSOME PROTEIN L4; RIBOSOME RNA; RNA 23S; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BARTONELLA HENSELAE; CAT SCRATCH DISEASE; CULTURE MEDIUM; GENE MUTATION; GENOTYPE; GROWTH INHIBITION; LYMPH NODE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; STRAIN IDENTIFICATION;

BARTONELLA HENSELAE; CAT-SCRATCH DISEASE; CHILD; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MACROLIDES; POINT MUTATION; RNA, RIBOSOMAL, 23S;

EID: 33748700249     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00263-06     Document Type: Article

References (18)

1. Anderson, B. E., and M. A. Neuman. 1997. Bartonella spp. as emerging human pathogens. Clin. Microbiol. Rev. 10:203-219.
2. Bass, J. W., B. C. Freitas, A. D. Freitas, C. L. Sisler, D. S. Chan, J. M. Vincent, D. A. Person, J. R. Claybaugh, R. R. Wittier, M. E. Weisse, R. L. Regnery, and L. N. Slater. 1998. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr. Infect. Dis. J. 17:447-452.
3. Branger, S., J. M. Rolain, and D. Raoult. 2004. Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob. Agents Chemother. 48:4822-4828.
4. Canu, A., B. Malbruny, M. Coquemont, T. A. Davies, P. C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
5. Farrell, D. J., S. Douthwaite, I. Morrissey, S. Bakker, J. Poehlsgaard, L. Jakobsen, and D. Felmingham. 2003. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob. Agents Chemother. 47:1777-1783.
6. Gregory, S. T., and A. E. Dahlberg. 1999. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S rRNA. J. Mol. Biol. 289:827-834.
7. Hansen, L. H., P. Mauvais, and S. Douthwaite. 1999. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S rRNA. Mol. Microbiol. 31:623-631.
8. Koehler, J. E., and J. W. Tappero. 1993. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:612-624.
9. Meghari, S., J. M. Rolain, G. E. Grau, E. Platt, L. Barrassi, J. L. Mege, and D. Raoult. 2006. Anti-angiogenic effect of erythromycin in Bartonella quintana: in vitro model of infection. J. Infect. Dis. 193:380-386.
10. Ng, L. K., I. Martin, G. Liu, and L. Bryden. 2002. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:3020-3025.
11. Pereyre, S., C. Guyot, H. Renaudin, A. Charron, C. Bebear, and C. M. Bebear. 2004. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 48:460-465.
12. Pernodet, J. L., F. Boccard, M. T. Alegre, M. H. Blondelet-Rouault, and M. Guerineau. 1988. Resistance to macrolides, lincosamides, and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J. 7:277-282.
13. Rolain, J. M., P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, and D. Raoult. 2004. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob. Agents Chemother. 48:1921-1933.
14. Rolain, J. M., M. Maurin, A. Bryskier, and D. Raoult. 2000. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowasekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44:1391-1393.
15. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
16. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
17. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.
18. Zeaiter, Z., P. E. Fournier, and D. Raoult. 2002. Genomic variation of Bartonella henselae strains detected in lymph nodes of patients with cat scratch disease. J. Clin. Microbiol. 40:1023-1030.